Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry-Reference-Cited by-同舟云学术

Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry

Published:2020-05 Issue:3 Volume:19 Page:376-383
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Hatziagorou Elpis^ORCID,Orenti Annalisa,Drevinek Pavel^ORCID,Kashirskaya Nataliya^ORCID,Mei-Zahav Meir,De Boeck Kris,Pfleger Andreas,Sciensano Muriel Thomas,Lammertyn Elise,Macek Milan,Olesen Hanne Vebert,Farge Anne,Naehrlich Lutz,Ujhelyi Rita,Fletcher Godfrey,Padoan Rita,Timpare Zane,Malakauskas Kęstutis,Fustik Stojka,Gulmans Vincent,Turcu Oxana,Pereira Luísa,Mosescu Simona,Rodic Milan,Kayserova Hana,Krivec Uroš,Vazquez-Cordero Carlos,de Monestrol Isabelle,Lindblad Anders,Jung Andreas,Makukh Halyna,Carr Siobhán B.,Cosgriff Rebecca,Zolin Anna

Funder

European CF Society Patient Registry

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference39 articles.

1. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life;Cohen-Cymberknoh;Am J Respir Crit Care Med,2011

2. Defining antimicrobial resistance in cystic fibrosis;Kidd;J Cyst Fibros,2018

3. ECFS best practice guidelines: the 2018 revision;Castellani;J Cyst Fibros,2018

4. Infection prevention and control guideline for cystic fibrosis: 2013 update;Schmidt;Infect Control Hosp Epidemiol,2014

5. Respiratory bacterial infections in cystic fibrosis;Ciofu;Curr Opin Pulm Med,2013

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and anthropometric evolution of individuals with cystic fibrosis during COVID‐19 pandemic: A 24‐month cohort study;Pediatric Pulmonology;2024-05-07

2. Safety and Pharmacokinetics Following Oral or Intravenous Lefamulin in Adults With Cystic Fibrosis;Clinical Therapeutics;2024-02

3. Cystic fibrosis in Europe: improved lung function and longevity – reasons for cautious optimism, but challenges remain;European Respiratory Journal;2024-02-01

4. The past, present and future of polymicrobial infection research: Modelling, eavesdropping, terraforming and other stories;Advances in Microbial Physiology;2024

5. Cystic Fibrosis-Related Nontuberculous Mycobacterial Pulmonary Disease;Clinics in Chest Medicine;2023-12